Annual EBITDA
-$9.89 M
+$4.96 M+33.41%
April 30, 2024
Summary
- As of February 8, 2025, ALZN annual EBITDA is -$9.89 million, with the most recent change of +$4.96 million (+33.41%) on April 30, 2024.
- During the last 3 years, ALZN annual EBITDA has fallen by -$5.00 million (-102.28%).
- ALZN annual EBITDA is now -124.18% below its all-time high of -$4.41 million, reached on April 30, 2020.
Performance
ALZN EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$1.35 M
-$395.70 K-41.67%
October 31, 2024
Summary
- As of February 8, 2025, ALZN quarterly EBITDA is -$1.35 million, with the most recent change of -$395.70 thousand (-41.67%) on October 31, 2024.
- Over the past year, ALZN quarterly EBITDA has dropped by -$395.70 thousand (-41.67%).
- ALZN quarterly EBITDA is now -60.66% below its all-time high of -$837.40 thousand, reached on April 30, 2024.
Performance
ALZN Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$5.78 M
+$1.54 M+21.08%
October 31, 2024
Summary
- As of February 8, 2025, ALZN TTM EBITDA is -$5.78 million, with the most recent change of +$1.54 million (+21.08%) on October 31, 2024.
- Over the past year, ALZN TTM EBITDA has increased by +$1.54 million (+21.08%).
- ALZN TTM EBITDA is now -359.87% below its all-time high of -$1.26 million, reached on April 30, 2020.
Performance
ALZN TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
ALZN EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +33.4% | -41.7% | +21.1% |
| 3 y3 years | -102.3% | -41.7% | +21.1% |
| 5 y5 years | -97.4% | -41.7% | +21.1% |
ALZN EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -102.3% | +33.4% | -60.7% | +75.2% | at high | +62.5% |
| 5 y | 5-year | -124.2% | +33.4% | -60.7% | +75.2% | -359.9% | +62.5% |
| alltime | all time | -124.2% | +33.4% | -60.7% | +75.2% | -359.9% | +62.5% |
Alzamend Neuro EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Oct 2024 | - | -$1.35 M(+41.7%) | -$5.78 M(-21.1%) |
| Jul 2024 | - | -$949.70 K(+13.4%) | -$7.32 M(-25.9%) |
| Apr 2024 | -$9.89 M(-33.4%) | -$837.40 K(-68.4%) | -$9.89 M(-19.9%) |
| Jan 2024 | - | -$2.65 M(-8.4%) | -$12.35 M(-18.3%) |
| Oct 2023 | - | -$2.89 M(-17.8%) | -$15.12 M(-1.4%) |
| Jul 2023 | - | -$3.51 M(+6.5%) | -$15.33 M(+3.3%) |
| Apr 2023 | -$14.85 M(+20.6%) | -$3.30 M(-39.1%) | -$14.85 M(-3.7%) |
| Jan 2023 | - | -$5.42 M(+74.7%) | -$15.41 M(+22.8%) |
| Oct 2022 | - | -$3.10 M(+2.4%) | -$12.55 M(-3.7%) |
| Jul 2022 | - | -$3.03 M(-21.6%) | -$13.03 M(+5.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Apr 2022 | -$12.31 M(+151.9%) | -$3.87 M(+51.2%) | -$12.31 M(+27.4%) |
| Jan 2022 | - | -$2.56 M(-28.7%) | -$9.67 M(+18.4%) |
| Oct 2021 | - | -$3.58 M(+55.4%) | -$8.16 M(+38.9%) |
| Jul 2021 | - | -$2.31 M(+89.0%) | -$5.88 M(+20.2%) |
| Apr 2021 | -$4.89 M(+10.8%) | -$1.22 M(+15.8%) | -$4.89 M(-0.7%) |
| Jan 2021 | - | -$1.05 M(-18.9%) | -$4.92 M(+27.2%) |
| Oct 2020 | - | -$1.30 M(-1.4%) | -$3.87 M(+50.4%) |
| Jul 2020 | - | -$1.32 M(+4.8%) | -$2.57 M(+104.8%) |
| Apr 2020 | -$4.41 M(-12.0%) | -$1.26 M | -$1.26 M |
| Apr 2019 | -$5.01 M | - | - |
FAQ
- What is Alzamend Neuro annual EBITDA?
- What is the all time high annual EBITDA for Alzamend Neuro?
- What is Alzamend Neuro annual EBITDA year-on-year change?
- What is Alzamend Neuro quarterly EBITDA?
- What is the all time high quarterly EBITDA for Alzamend Neuro?
- What is Alzamend Neuro quarterly EBITDA year-on-year change?
- What is Alzamend Neuro TTM EBITDA?
- What is the all time high TTM EBITDA for Alzamend Neuro?
- What is Alzamend Neuro TTM EBITDA year-on-year change?
What is Alzamend Neuro annual EBITDA?
The current annual EBITDA of ALZN is -$9.89 M
What is the all time high annual EBITDA for Alzamend Neuro?
Alzamend Neuro all-time high annual EBITDA is -$4.41 M
What is Alzamend Neuro annual EBITDA year-on-year change?
Over the past year, ALZN annual EBITDA has changed by +$4.96 M (+33.41%)
What is Alzamend Neuro quarterly EBITDA?
The current quarterly EBITDA of ALZN is -$1.35 M
What is the all time high quarterly EBITDA for Alzamend Neuro?
Alzamend Neuro all-time high quarterly EBITDA is -$837.40 K
What is Alzamend Neuro quarterly EBITDA year-on-year change?
Over the past year, ALZN quarterly EBITDA has changed by -$395.70 K (-41.67%)
What is Alzamend Neuro TTM EBITDA?
The current TTM EBITDA of ALZN is -$5.78 M
What is the all time high TTM EBITDA for Alzamend Neuro?
Alzamend Neuro all-time high TTM EBITDA is -$1.26 M
What is Alzamend Neuro TTM EBITDA year-on-year change?
Over the past year, ALZN TTM EBITDA has changed by +$1.54 M (+21.08%)